---
schema_version: "secwatch.filing_event.v1"
accession: "0001628908-25-000064"
form_type: "8-K"
ticker: "EVH"
cik: "0001628908"
company_name: "Evolent Health, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:37:54.620340+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Evolent Health Q1 revenue down 24% to $483.6M; net loss widens to $72.3M

## Summary
- Revenue $483.6M vs $639.7M YoY; net loss $72.3M vs $25.2M YoY.
- Adjusted EBITDA $36.9M (7.6% margin) vs $54.1M (8.5% margin) YoY.
- Five new revenue agreements added, including surgical management, oncology, and imaging expansions.
- Performance Suite lives declined to 6,486 from 7,050 YoY; specialty technology lives rose to 77,079.
- Company reiterates full-year 2025 revenue and Adjusted EBITDA outlook.

## SEC filing metadata
- accession: 0001628908-25-000064
- form_type: 8-K
- ticker: EVH
- cik: 0001628908
- company_name: Evolent Health, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628908/000162890825000064/0001628908-25-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628908/000162890825000064/evh-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628908-25-000064
- JSON: https://secwatch.observer/filing/0001628908-25-000064.json
- Plain text: https://secwatch.observer/filing/0001628908-25-000064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.